Atlas Trials

Study Evaluating The Efficacy And Safety Of SBI-087 In Seropositive Subjects With Active Rheumatoid Arthritis

Clinical trial NCT01008852 · COMPLETED

Trial details

NCT number
NCT01008852
Sponsor
Pfizer
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Active Rheumatoid Arthritis
Start date
2009-12-01
Primary completion
2011-09-01
Enrollment
210

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.